PONIARD PHARMACEUTICALS, INC.

• Accepted (ET)
• Apr 28-K—
  Current report0001193125-12-146142 · 21.8 KB
  SEC(opens sec.gov)
• Jan 58-K—
  Current report0001193125-12-003593 · 40.8 KB
  SEC(opens sec.gov)
• Dec 238-K—
  Current report0001193125-11-351898 · 47.6 KB
  SEC(opens sec.gov)
• Nov 228-K—
  Current report0001193125-11-319693 · 49.9 KB
  SEC(opens sec.gov)
• Nov 28-K—
  Current report0001193125-11-292727 · 93.7 KB
  SEC(opens sec.gov)
• Oct 2810-Q—
  Quarterly update0001193125-11-285826 · 2.2 MB
  SEC(opens sec.gov)
• Oct 128-K—
  Current report0001193125-11-269244 · 43.8 KB
  SEC(opens sec.gov)
• Oct 74—
  Insider trades0001179110-11-014114 · 7.2 KB
  SEC(opens sec.gov)
• Sep 78-K—
  Current report0001193125-11-242289 · 34.1 KB
  SEC(opens sec.gov)
• Aug 168-K—
  Current report0001193125-11-224102 · 90.5 KB
  SEC(opens sec.gov)

• BASSO ROBERT SDirector
• BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP10% Owner
• BAY CITY CAPITAL LLC10% Owner
• Berland Susan DCFO
• BOWMAN JACK LDirector
• CRAVES FRED BDirector
• EVNIN LUKE10% Owner
• GADICKE ANSBERT10% Owner
• GALAKATOS NICHOLAS10% Owner
• GHALIE RICHARD GInsider

No tickers on record.

• business

  750 BATTERY STREET SUITE 330

  SAN FRANCISCO, CA, 94111

• mailing

  300 ELLIOTT AVENUE WEST SUITE 530

  SEATTLE, WA, 98119-4114

• NEORX CORP2006-06-07